Gabriella Miller Kids First Pediatric Research
Active
- Assistance listing
- 93.1KF
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Treasury account
-
- 75-0846-0-1-552
- More information
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institutes of Health, through the Office of Strategic Coordination in the NIH Office of the Director, funds research investigating the shared genetic pathways between childhood cancer and congenital anomalies under the Gabriella Miller Kids First Pediatric Research program (CFDA 93.1KF). The source provided contains no recent grant awards, recent grant opportunities, or portfolio data to characterize award frequency, assistance-type mix, funding concentration, or typical award magnitudes.
The program supports research aimed at uncovering new insights into the biology of childhood cancer and congenital anomalies, with emphasis on identifying shared genetic mechanisms. The rationale rests on epidemiological observation: children with birth defects face increased risk of developing childhood cancer, suggesting common underlying genetic pathways. Awards are made to domestic public or private nonprofits, for-profits, universities, colleges, hospitals, laboratories, and other research institutions, including state and local government units; some funding opportunities accept foreign organization applicants, with specifics defined in individual Notices of Funding Opportunity.
Funding decisions turn on scientific merit and program relevance. Merit review addresses significance, approach, innovation, principal investigator competency, adequacy of resources and environment, proposed budget and period of support, and—where applicable—protections against adverse effects on humans, animals, or the environment. The peer review cycle runs four to nine months. Recipients must comply with OMB 2 CFR 200 audit requirements and retain financial, programmatic, and supporting records for three years from the annual Federal Service Reports submission date, subject to extensions if litigation, audit, or claims are unresolved.
No information in the source establishes current opportunity status, recent award history, typical award size, or current solicitation timeline. Potential applicants should consult NIH's grants portal and the program's Notices of Funding Opportunity for current solicitation status and eligibility constraints specific to each funding cycle.
Objective and description
- Objective
This listing covers the Gabriella Miller Kids First Pediatric Research program (Kids First), administered by the Office of Strategic Coordination (OSC) in the NIH Office of the Director which offers assistance awards or supplements to assistance awar
- Description
The goal of the Gabriella Miller Kids First Pediatric Research Program (Kids First) is to help researchers uncover new insights into the biology of childhood cancer and congenital anomalies, including the discovery of shared genetic pathways between these disorders. Children with birth defects have an increased risk of developing childhood cancer. This suggests there are shared genetic pathways underlying some types of childhood cancer and congenital anomalies.
Eligibility
- Applicant eligibility
Awards can be made to domestic, public or private, for-profit or nonprofit organization, university, college, hospital, laboratory, or other institution, including State and local units of government, and individuals. Some initiatives will accept applications from foreign organizations. Additional details on eligibility are specified in each Notice of Funding Opportunity.
- Uses of assistance
To support research and other projects that will accelerate fundamental biomedical discovery and translation of that knowledge into effective prevention strategies and new treatments.
How to apply
- Criteria for selecting proposals
Funding decisions are based on scientific merit (42 CFR 52h) and program relevance. Scientific merit review encompasses: the peer review criteria detailed in the specific funding announcement, as well as the significance, approach, and innovation of the proposed research; the competency of the principal investigator; the adequacy of the resources and environment; the proposed budget and requested period of support; and, where applicable, the adequacy of the measures for protecting against adverse effects upon humans, animals, or the environment.
- Award procedure
Applications are reviewed for scientific and technical merit by a scientific review group and for program relevance by a national advisory council/board.
- Time to approval or disapproval
Not Applicable. The length of the review cycle is four to nine months.
- Appeals
A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the NIH Scientific/Research contact, as provided on an initiative. A description of the NIH Peer Review Appeal procedures is available on the NIH Web site at http://grants.nih.gov/grants/guide/notice-files/not97-232.html .
Quick answers
What is Assistance Listing 93.1KF?
Assistance Listing 93.1KF is Gabriella Miller Kids First Pediatric Research, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Gabriella Miller Kids First Pediatric Research?
Its CFDA number is 93.1KF: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program